Agenus Announces Stock Symbol to Revert Back to AGEN
October 11, 2011 11:10 ET
|
Agenus Inc.
LEXINGTON, Mass., Oct. 11, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEND), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that in response to the...
Agenus to Present at Second Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference
October 03, 2011 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., Oct. 3, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be...
Agenus Announces Reverse Stock Split
September 30, 2011 13:00 ET
|
Agenus Inc.
LEXINGTON, Mass., Sept. 30, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that its board of directors has...
Clinical Data Published in Vaccine Demonstrate Robust Immune Response With Agenus' Herpes Vaccine Containing QS-21 Adjuvant
September 26, 2011 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., Sept. 26, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced positive results from a...
Agenus to Present at JMP Securities Healthcare Conference
September 22, 2011 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., Sept. 22, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a leading developer of therapeutic vaccines for cancer and infectious diseases, today announced that Dr. Garo Armen,...
Agenus to Present at Rodman & Renshaw Annual Global Investment Conference
September 09, 2011 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., Sept. 9, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a leading developer of therapeutic vaccines for cancer and infectious diseases, today announced that Dr. Garo Armen,...
Agenus Prices at Market Underwritten Offering of Common Stock
August 11, 2011 08:30 ET
|
Agenus Inc.
LEXINGTON, Mass., Aug. 11, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a leading developer of therapeutic vaccines for cancer and infectious diseases, today announced the pricing of an at...
Agenus Reports Second Quarter 2011 Financial Results and Corporate Updates
July 28, 2011 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., July 28, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) reported today its results for the quarter and six months ended June 30, 2011. The company reported a net loss...
Agenus to Report Second Quarter Financial Results on July 28, 2011; Conference Call to Follow
July 21, 2011 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., July 21, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) will release its second quarter financial results before the market opens on July 28, 2011.
Agenus executives will host...
Agenus' Herpes Study Results Presented at BIO International Convention Show Robust Immune Response
June 27, 2011 07:00 ET
|
Agenus Inc.
LEXINGTON, Mass., June 27, 2011 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a leading developer of therapeutic vaccines for cancer and infectious diseases, today announced that results from its...